1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Teriete, P.
Banerji, S.
Blundell, C.D.
Kahmann, J.D.
Pickford, A.R.
Wright, A.J.
Campbell, I.D.
Jackson, D.G.
Day, A.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Mol.Cell
MOCEFL
2168
1097-2765
13
483
496
10.1016/S1097-2765(04)00080-2
14992719
Structure of the Regulatory Hyaluronan Binding Domain in the Inflammatory Leukocyte Homing Receptor CD44.
2004
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
56
1057
1062
10.1016/0092-8674(89)90638-7
A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family.
1989
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
56
1063
1072
10.1016/0092-8674(89)90639-9
A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins.
1989
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
61
1303
1313
10.1016/0092-8674(90)90694-A
CD44 is the principal cell surface receptor for hyaluronate.
1990
US
J.Cell Biol.
JCLBA3
2019
0021-9525
122
257
264
10.1083/jcb.122.1.257
Identification of hyaluronic acid binding sites in the extracellular domain of CD44.
1993
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
86
767
775
10.1016/S0092-8674(00)80151-8
Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix
Stability and Cell Migration
1996
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
273
338
343
10.1074/jbc.273.1.338
Identification of CD44 residues important for hyaluronan binding and delineation of the binding site
1998
US
Cancer Res.
CNREA8
0400
0008-5472
58
3736
3742
Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding
1998
US
Protein Expr.Purif.
PEXPEJ
0757
1046-5928
14
371
381
10.1006/prep.1998.0971
Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli
1998
10.2210/pdb1poz/pdb
pdb_00001poz
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
17601.486
CD44 antigen
HYALURONAN BINDING DOMAIN
1
man
polymer
Phagocytic glycoprotein I, PGP-1, HUTCH-I, Extracellular matrix receptor-III, ECMR-III, GP90 lymphocyte homing/adhesion receptor, Hermes antigen, Hyaluronate receptor, Heparan sulfate proteoglycan, Epican, CDw44
no
no
AQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAA
NNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDV
AQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAA
NNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDV
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
CD44
9606
Homo sapiens
562
Escherichia coli
BL21(DE3)pLysS
pET Vector
pET19b
atom_site
database_2
diffrn
diffrn_radiation
diffrn_radiation_wavelength
pdbx_nmr_exptl_sample
pdbx_nmr_sample_details
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Atomic model
Data collection
Database references
Derived calculations
Experimental preparation
1
0
2004-03-16
1
1
2008-04-29
1
2
2011-07-13
2
0
2021-10-27
_atom_site.occupancy
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_sample_details.contents
_pdbx_nmr_sample_details.label
_pdbx_nmr_sample_details.solvent_system
_pdbx_nmr_sample_details.type
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.manufacturer
_pdbx_nmr_spectrometer.model
Link module of the human TSG-6
Conformation of the bound Link module of the human TSG-6 to a hyaluronic acid octamer.
RCSB
Y
RCSB
2003-06-16
REL
REL
structures with the least restraint violations,structures with the lowest energy,target function
500
20
3D_15N-separated_NOESY
2D NOESY
2D NOESY
2D TOCSY
HMQC-J
CBCA(CO)NH
NH-Exchange HSQC
1
mM
[U-13C; U-15N]
1
mM
[U-15N]
1
mM
[U-15N]
1
mM
natural abundance
1
mM
natural abundance
<5mM
6.5
ambient
298
K
The structures are calculated from 2271 restraints, 2168 are NOE based, 47 dihedral constraints and 56 distance restraints from hydrogen bonds
torsion angle dynamics
simulated annealing
refinement by molecular dynamics
1
lowest energy
1 mM [U-13C; U-15N] protein, 95% H2O/5% D2O
sample_1
95% H2O/5% D2O
solution
1 mM [U-15N] protein, 95% H2O/5% D2O
sample_2
95% H2O/5% D2O
solution
1 mM [U-15N] protein, 100% D2O
sample_3
100% D2O
solution
1 mM protein, 95% H2O/5% D2O
sample_4
95% H2O/5% D2O
solution
1 mM protein, 100% D2O
sample_5
100% D2O
solution
Brunger, A.T.
structure solution
CNS
1.1
MSI, San Diego
processing
Felix
2.3
Pickford, A.R.
structure solution
SOPHIE
1.0
Goddard, T.D.
data analysis
Sparky
2.0
Xia, T
data analysis
XEASY
3.13
Pickford, A.R.
refinement
SOPHIE
1.0
750
GE
OMEGA
600
GE
OMEGA
500
GE
OMEGA
ALA
20
n
1
ALA
20
A
GLN
21
n
2
GLN
21
A
ILE
22
n
3
ILE
22
A
ASP
23
n
4
ASP
23
A
LEU
24
n
5
LEU
24
A
ASN
25
n
6
ASN
25
A
ILE
26
n
7
ILE
26
A
THR
27
n
8
THR
27
A
CYS
28
n
9
CYS
28
A
ARG
29
n
10
ARG
29
A
PHE
30
n
11
PHE
30
A
ALA
31
n
12
ALA
31
A
GLY
32
n
13
GLY
32
A
VAL
33
n
14
VAL
33
A
PHE
34
n
15
PHE
34
A
HIS
35
n
16
HIS
35
A
VAL
36
n
17
VAL
36
A
GLU
37
n
18
GLU
37
A
LYS
38
n
19
LYS
38
A
ASN
39
n
20
ASN
39
A
GLY
40
n
21
GLY
40
A
ARG
41
n
22
ARG
41
A
TYR
42
n
23
TYR
42
A
SER
43
n
24
SER
43
A
ILE
44
n
25
ILE
44
A
SER
45
n
26
SER
45
A
ARG
46
n
27
ARG
46
A
THR
47
n
28
THR
47
A
GLU
48
n
29
GLU
48
A
ALA
49
n
30
ALA
49
A
ALA
50
n
31
ALA
50
A
ASP
51
n
32
ASP
51
A
LEU
52
n
33
LEU
52
A
CYS
53
n
34
CYS
53
A
LYS
54
n
35
LYS
54
A
ALA
55
n
36
ALA
55
A
PHE
56
n
37
PHE
56
A
ASN
57
n
38
ASN
57
A
SER
58
n
39
SER
58
A
THR
59
n
40
THR
59
A
LEU
60
n
41
LEU
60
A
PRO
61
n
42
PRO
61
A
THR
62
n
43
THR
62
A
MET
63
n
44
MET
63
A
ALA
64
n
45
ALA
64
A
GLN
65
n
46
GLN
65
A
MET
66
n
47
MET
66
A
GLU
67
n
48
GLU
67
A
LYS
68
n
49
LYS
68
A
ALA
69
n
50
ALA
69
A
LEU
70
n
51
LEU
70
A
SER
71
n
52
SER
71
A
ILE
72
n
53
ILE
72
A
GLY
73
n
54
GLY
73
A
PHE
74
n
55
PHE
74
A
GLU
75
n
56
GLU
75
A
THR
76
n
57
THR
76
A
CYS
77
n
58
CYS
77
A
ARG
78
n
59
ARG
78
A
TYR
79
n
60
TYR
79
A
GLY
80
n
61
GLY
80
A
PHE
81
n
62
PHE
81
A
ILE
82
n
63
ILE
82
A
GLU
83
n
64
GLU
83
A
GLY
84
n
65
GLY
84
A
HIS
85
n
66
HIS
85
A
VAL
86
n
67
VAL
86
A
VAL
87
n
68
VAL
87
A
ILE
88
n
69
ILE
88
A
PRO
89
n
70
PRO
89
A
ARG
90
n
71
ARG
90
A
ILE
91
n
72
ILE
91
A
HIS
92
n
73
HIS
92
A
PRO
93
n
74
PRO
93
A
ASN
94
n
75
ASN
94
A
SER
95
n
76
SER
95
A
ILE
96
n
77
ILE
96
A
CYS
97
n
78
CYS
97
A
ALA
98
n
79
ALA
98
A
ALA
99
n
80
ALA
99
A
ASN
100
n
81
ASN
100
A
ASN
101
n
82
ASN
101
A
THR
102
n
83
THR
102
A
GLY
103
n
84
GLY
103
A
VAL
104
n
85
VAL
104
A
TYR
105
n
86
TYR
105
A
ILE
106
n
87
ILE
106
A
LEU
107
n
88
LEU
107
A
THR
108
n
89
THR
108
A
SER
109
n
90
SER
109
A
ASN
110
n
91
ASN
110
A
THR
111
n
92
THR
111
A
SER
112
n
93
SER
112
A
GLN
113
n
94
GLN
113
A
TYR
114
n
95
TYR
114
A
ASP
115
n
96
ASP
115
A
THR
116
n
97
THR
116
A
TYR
117
n
98
TYR
117
A
CYS
118
n
99
CYS
118
A
PHE
119
n
100
PHE
119
A
ASN
120
n
101
ASN
120
A
ALA
121
n
102
ALA
121
A
SER
122
n
103
SER
122
A
ALA
123
n
104
ALA
123
A
PRO
124
n
105
PRO
124
A
PRO
125
n
106
PRO
125
A
GLU
126
n
107
GLU
126
A
GLU
127
n
108
GLU
127
A
ASP
128
n
109
ASP
128
A
CYS
129
n
110
CYS
129
A
THR
130
n
111
THR
130
A
SER
131
n
112
SER
131
A
VAL
132
n
113
VAL
132
A
THR
133
n
114
THR
133
A
ASP
134
n
115
ASP
134
A
LEU
135
n
116
LEU
135
A
PRO
136
n
117
PRO
136
A
ASN
137
n
118
ASN
137
A
ALA
138
n
119
ALA
138
A
PHE
139
n
120
PHE
139
A
ASP
140
n
121
ASP
140
A
GLY
141
n
122
GLY
141
A
PRO
142
n
123
PRO
142
A
ILE
143
n
124
ILE
143
A
THR
144
n
125
THR
144
A
ILE
145
n
126
ILE
145
A
THR
146
n
127
THR
146
A
ILE
147
n
128
ILE
147
A
VAL
148
n
129
VAL
148
A
ASN
149
n
130
ASN
149
A
ARG
150
n
131
ARG
150
A
ASP
151
n
132
ASP
151
A
GLY
152
n
133
GLY
152
A
THR
153
n
134
THR
153
A
ARG
154
n
135
ARG
154
A
TYR
155
n
136
TYR
155
A
VAL
156
n
137
VAL
156
A
GLN
157
n
138
GLN
157
A
LYS
158
n
139
LYS
158
A
GLY
159
n
140
GLY
159
A
GLU
160
n
141
GLU
160
A
TYR
161
n
142
TYR
161
A
ARG
162
n
143
ARG
162
A
THR
163
n
144
THR
163
A
ASN
164
n
145
ASN
164
A
PRO
165
n
146
PRO
165
A
GLU
166
n
147
GLU
166
A
ASP
167
n
148
ASP
167
A
ILE
168
n
149
ILE
168
A
TYR
169
n
150
TYR
169
A
PRO
170
n
151
PRO
170
A
SER
171
n
152
SER
171
A
ASN
172
n
153
ASN
172
A
PRO
173
n
154
PRO
173
A
THR
174
n
155
THR
174
A
ASP
175
n
156
ASP
175
A
ASP
176
n
157
ASP
176
A
ASP
177
n
158
ASP
177
A
VAL
178
n
159
VAL
178
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
22
A
N
ILE
3
A
O
THR
144
A
O
THR
125
A
N
ILE
147
A
N
ILE
128
A
O
TYR
155
A
O
TYR
136
A
N
ILE
22
A
N
ILE
3
A
O
THR
144
A
O
THR
125
A
N
ILE
143
A
N
ILE
124
A
O
GLY
159
A
O
GLY
140
A
N
PHE
30
A
N
PHE
11
A
O
VAL
33
A
O
VAL
14
A
N
THR
59
A
N
THR
40
A
O
PHE
119
A
O
PHE
100
A
O
VAL
87
A
O
VAL
68
A
N
GLY
80
A
N
GLY
61
A
N
PHE
81
A
N
PHE
62
A
O
ASP
115
A
O
ASP
96
1
A
A
HE2
HB3
HIS
ASP
35
115
1.28
1
A
A
HA3
HE1
GLY
TYR
80
117
1.33
1
A
A
HD1
HG23
HIS
THR
35
76
1.34
2
A
A
HG3
HB2
ARG
PHE
29
34
1.25
2
A
A
HA
H
PHE
ASP
30
128
1.29
2
A
A
HD1
HG22
HIS
THR
35
76
1.30
2
A
A
O
HA
CYS
PHE
28
34
1.57
3
A
A
HD1
HG21
HIS
THR
35
76
1.27
3
A
A
HG2
H
ARG
ALA
78
98
1.29
3
A
A
HG12
HE2
VAL
TYR
132
155
1.30
3
A
A
HB2
HE1
CYS
PHE
28
30
1.33
3
A
A
HB
HB3
THR
HIS
27
35
1.34
4
A
A
HG3
HB2
ARG
PHE
29
34
1.30
4
A
A
H
HG13
THR
ILE
133
147
1.31
4
A
A
HB2
HG3
SER
GLN
45
113
1.34
4
A
A
HD11
HD12
LEU
ILE
24
147
1.35
5
A
A
HA
HB2
THR
GLN
62
65
1.17
5
A
A
HG3
HB2
ARG
PHE
29
34
1.22
5
A
A
HG13
H
ILE
GLU
82
83
1.25
5
A
A
HD1
HG21
HIS
THR
35
76
1.29
5
A
A
O
HA
CYS
PHE
28
34
1.58
6
A
A
HG3
HB2
ARG
PHE
29
34
1.24
6
A
A
HB2
HE1
CYS
PHE
28
30
1.32
6
A
A
HG13
H
ILE
GLU
82
83
1.35
7
A
A
HG3
HB2
ARG
PHE
29
34
1.29
7
A
A
HD12
H
LEU
ASN
107
110
1.30
7
A
A
HG13
H
ILE
GLU
82
83
1.34
7
A
A
HG
H
LEU
SER
107
109
1.34
7
A
A
H
HE2
VAL
TYR
132
155
1.34
8
A
A
HG3
HB2
ARG
PHE
29
34
1.29
8
A
A
HE2
HB3
HIS
ASP
35
115
1.30
8
A
A
HD12
HA
LEU
LYS
24
38
1.33
9
A
A
HB3
HE1
CYS
PHE
28
30
1.18
9
A
A
HD1
HG21
HIS
THR
35
76
1.25
9
A
A
HB
HB3
THR
HIS
27
35
1.33
9
A
A
HB1
HB3
ALA
LEU
55
135
1.34
10
A
A
HB2
HE1
CYS
PHE
28
30
1.19
10
A
A
HG3
HB2
ARG
PHE
29
34
1.31
10
A
A
HD13
HG13
ILE
ILE
22
143
1.33
10
A
A
HB3
HA
LEU
ILE
24
147
1.34
10
A
A
H
HE2
VAL
TYR
132
155
1.34
10
A
A
HG13
H
ILE
GLU
82
83
1.34
11
A
A
HB3
HE1
CYS
PHE
28
30
1.21
11
A
A
HD1
HG23
HIS
THR
35
76
1.25
11
A
A
HB2
HG22
ALA
THR
49
116
1.33
11
A
A
HG23
HG22
ILE
ILE
26
147
1.34
11
A
A
H
HA
ALA
GLU
31
127
1.34
12
A
A
HA2
HB2
GLY
ALA
32
123
1.25
12
A
A
HD1
HG21
HIS
THR
35
76
1.31
12
A
A
HB3
HB
LEU
ILE
70
91
1.31
12
A
A
HB3
H
ASN
SER
94
95
1.32
12
A
A
HG13
H
ILE
GLU
82
83
1.33
12
A
A
O
O
ALA
PRO
31
124
2.15
13
A
A
HD2
HE22
PRO
GLN
61
65
1.20
13
A
A
HG3
HB2
ARG
PHE
29
34
1.24
13
A
A
HB3
HE1
CYS
PHE
28
30
1.34
13
A
A
O
H
TYR
TYR
42
114
1.48
14
A
A
HG3
HB2
ARG
PHE
29
34
1.22
14
A
A
HA3
HE1
GLY
TYR
80
117
1.26
14
A
A
H
HE2
VAL
TYR
132
155
1.30
14
A
A
HB3
HB
LEU
ILE
70
91
1.33
14
A
A
HB3
H
LYS
ASN
38
39
1.34
15
A
A
HB2
HB3
ALA
LEU
55
135
1.22
15
A
A
HG
H
LEU
SER
70
71
1.33
15
A
A
HG13
H
ILE
GLU
82
83
1.34
15
A
A
O
HA
CYS
PHE
28
34
1.60
16
A
A
HG3
HB2
ARG
PHE
29
34
1.17
16
A
A
HB3
HE1
CYS
PHE
28
30
1.19
16
A
A
H
HD2
CYS
TYR
97
105
1.27
16
A
A
HD1
HG22
HIS
THR
35
76
1.28
16
A
A
HB
HB3
ILE
TYR
88
105
1.34
16
A
A
O
H
ILE
ARG
26
150
1.55
17
A
A
HD1
HG23
HIS
THR
35
76
1.25
17
A
A
HG3
HB2
ARG
PHE
29
34
1.26
18
A
A
HG22
HB2
VAL
LEU
86
107
1.29
18
A
A
HE2
HB3
HIS
ASP
35
115
1.29
18
A
A
O
HA
CYS
PHE
28
34
1.59
19
A
A
HB3
HE1
CYS
PHE
28
30
1.17
19
A
A
HG3
HB3
ARG
PHE
29
34
1.25
19
A
A
O
HB2
ASN
GLU
25
37
1.59
20
A
A
HA
HB2
THR
GLN
62
65
1.26
20
A
A
HB2
HE1
CYS
PHE
28
30
1.27
20
A
A
HG3
HB2
ARG
PHE
29
34
1.34
20
A
A
H
HG22
GLN
ILE
21
168
1.34
20
A
A
HD21
HB3
ASN
SER
120
122
1.35
1
A
ASN
25
-160.07
105.81
1
A
CYS
28
154.75
167.85
1
A
ALA
31
48.80
28.05
1
A
ASN
39
29.01
35.19
1
A
ARG
41
28.95
87.39
1
A
TYR
42
80.66
-6.41
1
A
ALA
49
-48.64
-71.20
1
A
PHE
56
-107.18
56.93
1
A
ASN
57
34.40
83.15
1
A
LEU
60
-36.74
147.48
1
A
PRO
61
-59.63
83.58
1
A
CYS
77
56.24
15.63
1
A
GLU
83
-39.50
-33.74
1
A
HIS
85
-174.66
144.02
1
A
ARG
90
-171.03
58.87
1
A
ILE
96
-163.63
-34.58
1
A
CYS
97
-70.52
-75.35
1
A
ALA
98
-66.58
-81.11
1
A
ALA
99
-158.77
-76.96
1
A
ASN
100
-135.05
-61.56
1
A
VAL
104
36.28
49.53
1
A
THR
108
-159.87
55.14
1
A
SER
109
-142.23
-155.74
1
A
SER
112
-172.77
-102.00
1
A
GLN
113
-164.81
-169.29
1
A
TYR
114
-163.38
-161.51
1
A
CYS
118
-170.80
121.88
1
A
SER
122
-45.76
-76.89
1
A
PRO
124
-67.69
-175.30
1
A
PRO
125
-58.62
76.76
1
A
SER
131
-55.02
89.30
1
A
VAL
132
-44.01
-88.28
1
A
THR
133
48.01
8.31
1
A
ASP
134
-88.09
-79.34
1
A
PRO
136
-57.45
2.34
1
A
ALA
138
-109.37
-154.46
1
A
ARG
150
28.05
-76.39
1
A
ASP
151
-156.91
16.53
1
A
TYR
161
-173.43
-30.33
1
A
ILE
168
-102.54
-74.23
1
A
SER
171
-94.83
-77.61
1
A
ASP
175
-164.54
98.35
2
A
ASN
25
-160.02
102.15
2
A
CYS
28
127.49
175.85
2
A
ARG
29
-109.05
79.15
2
A
ALA
31
71.55
-13.52
2
A
ASN
39
-46.86
95.87
2
A
ARG
41
-68.38
-154.81
2
A
TYR
42
159.85
-5.16
2
A
SER
45
-115.00
-165.33
2
A
ALA
49
-55.62
-73.16
2
A
ASP
51
-62.91
-75.28
2
A
PHE
56
-95.52
40.24
2
A
CYS
77
-98.85
42.77
2
A
ILE
82
-107.18
-158.81
2
A
GLU
83
-47.14
-15.24
2
A
HIS
85
-172.04
140.04
2
A
PRO
89
-65.84
-131.93
2
A
ARG
90
68.49
68.83
2
A
ILE
91
-37.89
-75.41
2
A
PRO
93
-67.69
-87.58
2
A
ASN
94
-151.24
20.72
2
A
ILE
96
-81.78
-72.18
2
A
ALA
99
65.00
-160.66
2
A
THR
108
-140.99
59.40
2
A
SER
109
-164.66
-20.70
2
A
ASN
110
60.20
-89.33
2
A
THR
111
60.67
-94.91
2
A
SER
112
-92.84
-90.92
2
A
GLN
113
-166.60
-114.16
2
A
TYR
114
166.73
-171.55
2
A
CYS
118
-172.74
121.35
2
A
GLU
126
178.88
136.53
2
A
GLU
127
-15.30
108.14
2
A
THR
130
-48.92
167.91
2
A
VAL
132
-52.64
-81.41
2
A
THR
133
45.18
15.30
2
A
ASP
134
-80.89
-101.19
2
A
ALA
138
-61.92
-159.76
2
A
PRO
142
-66.81
10.42
2
A
THR
144
-66.30
84.32
2
A
GLU
160
-178.12
145.82
2
A
TYR
161
-178.10
-27.94
2
A
SER
171
59.17
95.93
2
A
ASP
177
58.46
-166.05
3
A
CYS
28
115.70
170.16
3
A
ALA
31
58.92
5.01
3
A
ASN
39
-50.01
96.60
3
A
ARG
41
-67.57
-162.58
3
A
TYR
42
169.46
-0.50
3
A
SER
45
-108.32
-161.90
3
A
ALA
49
-54.31
-75.76
3
A
ASP
51
-58.84
-75.24
3
A
PHE
56
-87.44
46.71
3
A
ASN
57
50.54
72.27
3
A
LEU
60
-37.42
102.21
3
A
ARG
78
159.43
-105.75
3
A
TYR
79
-34.30
129.91
3
A
HIS
85
-171.90
144.90
3
A
ARG
90
-174.43
47.31
3
A
PRO
93
-73.94
31.18
3
A
ILE
96
-130.97
-80.70
3
A
ALA
98
-65.04
-95.58
3
A
ALA
99
176.23
-62.68
3
A
ASN
100
-93.07
-116.50
3
A
ASN
101
175.32
147.70
3
A
THR
102
-170.00
-11.80
3
A
THR
111
-145.27
-75.48
3
A
SER
112
-137.00
-95.50
3
A
GLN
113
-161.17
-117.71
3
A
TYR
114
154.07
-143.69
3
A
PRO
125
-64.83
66.99
3
A
GLU
126
171.38
-137.40
3
A
GLU
127
72.87
-143.59
3
A
ASP
128
173.05
-90.06
3
A
CYS
129
-110.38
-95.42
3
A
THR
130
65.90
144.57
3
A
SER
131
-58.57
98.63
3
A
THR
133
-57.58
9.50
3
A
ASP
134
-66.69
-85.29
3
A
PRO
136
-64.64
0.48
3
A
ALA
138
-67.76
-164.84
3
A
PRO
142
-70.06
26.76
3
A
THR
144
-67.63
78.79
3
A
GLU
160
-164.01
100.17
3
A
ARG
162
-80.43
44.99
3
A
ASP
175
-108.48
-73.02
4
A
CYS
28
143.82
179.96
4
A
PHE
30
-79.96
-120.76
4
A
ALA
31
-43.07
-8.86
4
A
TYR
42
-71.82
37.97
4
A
SER
45
-129.06
-141.27
4
A
ALA
49
-47.60
-72.27
4
A
ALA
50
-37.50
-38.80
4
A
PHE
56
-108.34
54.22
4
A
ASN
57
39.91
86.50
4
A
LEU
60
-46.93
154.49
4
A
ILE
82
-109.80
-152.28
4
A
ARG
90
-173.44
47.87
4
A
ALA
98
58.29
-89.38
4
A
ALA
99
-154.97
-79.96
4
A
ASN
100
-145.65
-36.01
4
A
VAL
104
-69.55
90.71
4
A
SER
109
-164.73
-167.27
4
A
SER
112
-156.41
-100.96
4
A
GLN
113
-122.57
-96.27
4
A
TYR
114
108.56
-163.35
4
A
GLU
126
-178.50
-84.31
4
A
SER
131
-67.39
90.77
4
A
VAL
132
-42.71
-90.79
4
A
THR
133
44.44
12.81
4
A
ASP
134
-87.86
-78.96
4
A
PRO
136
-59.95
-2.10
4
A
ALA
138
-101.55
-163.31
4
A
PRO
142
-68.63
2.64
4
A
ARG
150
-59.58
-0.85
4
A
GLU
160
-171.19
140.53
4
A
TYR
161
-175.77
-33.43
4
A
ASN
164
-150.67
84.65
4
A
ASP
167
83.21
26.56
4
A
ILE
168
53.79
11.34
4
A
TYR
169
33.98
79.03
4
A
ASP
175
-161.00
-51.97
4
A
ASP
176
59.56
15.48
4
A
ASP
177
57.29
16.23
5
A
CYS
28
137.37
177.85
5
A
ARG
29
-109.66
79.14
5
A
ALA
31
62.62
-3.98
5
A
ASN
39
-56.93
0.00
5
A
ARG
41
30.72
83.87
5
A
TYR
42
87.48
-6.75
5
A
ALA
49
-49.78
-73.17
5
A
ASP
51
-51.89
-78.75
5
A
PHE
56
-97.64
42.76
5
A
PRO
61
-60.22
23.41
5
A
THR
62
-46.28
-1.21
5
A
CYS
77
56.17
17.74
5
A
ILE
82
-105.87
-149.14
5
A
GLU
83
-56.28
-6.65
5
A
ARG
90
177.39
36.75
5
A
ILE
91
29.76
-104.44
5
A
HIS
92
-175.52
45.04
5
A
PRO
93
-80.11
-73.33
5
A
ASN
94
-160.02
15.59
5
A
SER
95
59.67
84.06
5
A
CYS
97
-98.43
-72.74
5
A
ALA
98
-67.51
-96.62
5
A
ALA
99
-176.13
-54.26
5
A
ASN
100
-60.00
-96.84
5
A
ASN
101
-177.35
-167.62
5
A
THR
102
54.35
-172.94
5
A
THR
111
-155.27
-72.39
5
A
SER
112
-165.49
-96.57
5
A
GLN
113
-149.56
-153.99
5
A
TYR
114
-176.69
-163.16
5
A
ASP
115
-85.54
-158.14
5
A
GLU
126
177.73
-67.52
5
A
GLU
127
179.35
124.79
5
A
THR
130
-46.76
161.67
5
A
VAL
132
-56.08
-84.81
5
A
THR
133
49.50
9.38
5
A
ASP
134
-76.55
-101.83
5
A
ALA
138
-61.13
-170.15
5
A
PRO
142
-68.71
19.51
5
A
ASP
151
-79.74
25.91
5
A
TYR
161
-143.62
-45.91
5
A
THR
163
-81.72
43.61
5
A
ILE
168
-105.11
-66.46
5
A
ASP
176
-156.08
-54.31
6
A
CYS
28
121.75
173.80
6
A
ALA
31
62.29
-0.02
6
A
SER
43
172.94
-63.44
6
A
ALA
49
-51.46
-72.92
6
A
ALA
50
-25.73
-48.45
6
A
ASP
51
-61.34
-70.70
6
A
PHE
56
-104.81
54.40
6
A
ASN
57
29.90
78.96
6
A
ILE
82
-120.14
-166.31
6
A
HIS
85
-164.40
-164.22
6
A
PRO
89
-66.24
-172.82
6
A
ARG
90
-169.30
-46.11
6
A
ILE
91
59.31
-85.54
6
A
ILE
96
-150.71
-35.91
6
A
CYS
97
-70.73
-80.95
6
A
ALA
99
59.65
-164.25
6
A
ASN
100
58.14
-91.73
6
A
VAL
104
37.17
47.42
6
A
THR
111
-168.84
-31.89
6
A
SER
112
-76.51
-104.03
6
A
TYR
114
174.87
152.67
6
A
ASP
115
-79.98
-167.45
6
A
GLU
126
-178.15
-60.69
6
A
GLU
127
-170.98
127.94
6
A
THR
130
-63.06
-147.54
6
A
THR
133
-57.26
11.21
6
A
LEU
135
-143.48
45.60
6
A
PRO
142
-71.30
32.46
6
A
ARG
150
-54.68
-3.80
6
A
GLU
160
-161.22
116.50
6
A
TYR
161
-145.83
33.82
6
A
ARG
162
-80.07
38.80
6
A
ASP
177
58.57
-166.73
7
A
CYS
28
138.33
176.60
7
A
ARG
29
-109.83
79.75
7
A
ALA
31
64.35
-8.53
7
A
ASN
39
-41.72
90.32
7
A
SER
43
165.36
-40.96
7
A
ILE
44
174.63
172.07
7
A
SER
45
-123.31
-168.77
7
A
ALA
49
-49.95
-71.57
7
A
PHE
56
-112.65
65.92
7
A
ASN
57
20.28
70.63
7
A
THR
62
-105.76
-165.73
7
A
TYR
79
-63.40
76.17
7
A
ILE
82
-106.43
-159.50
7
A
ARG
90
176.45
49.85
7
A
ILE
91
30.39
-104.46
7
A
HIS
92
-178.08
52.66
7
A
ASN
94
-150.78
-9.78
7
A
CYS
97
-94.03
-71.56
7
A
ALA
98
-65.94
-83.41
7
A
ALA
99
-150.44
-80.19
7
A
ASN
100
-141.39
-44.78
7
A
THR
108
-80.06
33.19
7
A
SER
109
50.75
17.59
7
A
ASN
110
-81.29
-80.30
7
A
TYR
114
177.17
171.01
7
A
GLU
126
-175.94
-75.64
7
A
GLU
127
-169.75
113.00
7
A
THR
133
-62.53
16.70
7
A
ASP
134
-72.09
-106.70
7
A
PRO
136
-59.54
0.48
7
A
ALA
138
-57.95
-172.40
7
A
PHE
139
-107.88
-167.23
7
A
PRO
142
-73.37
29.76
7
A
ASP
151
-79.15
23.74
7
A
TYR
161
-176.92
29.43
7
A
ARG
162
-79.88
-72.75
7
A
THR
163
66.80
-15.32
7
A
PRO
173
-59.66
-71.62
7
A
THR
174
-152.53
-17.45
7
A
ASP
176
55.62
-163.56
8
A
CYS
28
121.48
173.56
8
A
ALA
31
57.24
8.36
8
A
LYS
38
-102.74
79.40
8
A
ASN
39
32.85
27.70
8
A
ARG
41
26.62
82.75
8
A
TYR
42
85.62
0.70
8
A
SER
43
-140.07
41.32
8
A
ALA
49
-41.31
-73.64
8
A
CYS
53
-38.52
-36.34
8
A
PHE
56
-103.43
57.06
8
A
ASN
57
34.53
81.29
8
A
LEU
60
-38.79
140.75
8
A
PRO
61
-62.78
92.33
8
A
GLU
75
-171.72
-30.33
8
A
THR
76
65.61
-16.28
8
A
CYS
77
55.12
10.06
8
A
ILE
82
-109.70
-167.34
8
A
HIS
85
-166.32
-160.90
8
A
ARG
90
177.68
45.74
8
A
ILE
91
39.05
-107.82
8
A
HIS
92
178.51
51.38
8
A
PRO
93
-73.51
-76.03
8
A
ASN
94
-160.01
29.93
8
A
SER
95
63.06
101.30
8
A
ILE
96
-130.86
-72.58
8
A
ASN
100
-162.77
-157.74
8
A
VAL
104
-118.73
70.48
8
A
GLN
113
175.62
54.25
8
A
TYR
114
-155.22
-153.97
8
A
PRO
125
-65.93
79.43
8
A
GLU
126
179.19
164.06
8
A
THR
130
-37.06
138.44
8
A
SER
131
-58.09
96.42
8
A
VAL
132
-79.50
23.41
8
A
THR
133
-61.13
7.72
8
A
ASP
134
-76.45
-77.91
8
A
ALA
138
-62.90
-162.15
8
A
PRO
142
-71.28
35.61
8
A
THR
144
-66.57
77.93
8
A
ARG
150
-56.65
-2.74
8
A
GLU
160
-163.56
102.49
8
A
ASP
175
-159.31
-70.06
9
A
CYS
28
127.50
169.08
9
A
ALA
31
49.69
21.95
9
A
LYS
38
80.69
-108.36
9
A
ASN
39
-59.45
-8.48
9
A
TYR
42
63.29
-9.11
9
A
SER
43
-161.24
46.61
9
A
SER
45
-131.97
-159.86
9
A
GLU
48
-54.36
-77.49
9
A
CYS
53
-35.35
-36.25
9
A
PHE
56
-97.56
54.49
9
A
ASN
57
40.01
82.05
9
A
LEU
60
-45.11
109.09
9
A
THR
62
-109.12
-159.97
9
A
TYR
79
-65.27
94.26
9
A
HIS
85
-165.97
-161.74
9
A
ARG
90
-154.68
61.00
9
A
SER
95
-56.61
-72.44
9
A
ILE
96
72.46
-24.19
9
A
CYS
97
-104.97
-70.39
9
A
ALA
98
-58.56
-83.39
9
A
ALA
99
-161.30
-74.93
9
A
ASN
100
-134.68
-66.46
9
A
VAL
104
36.93
47.71
9
A
SER
109
-141.10
-82.16
9
A
ASN
110
-167.03
-148.99
9
A
GLN
113
-177.84
53.43
9
A
TYR
114
-147.72
-150.65
9
A
CYS
118
-169.92
119.93
9
A
SER
122
-47.69
-76.12
9
A
PRO
124
-55.10
-178.77
9
A
PRO
125
-62.18
81.84
9
A
GLU
126
-173.40
148.55
9
A
SER
131
-59.30
83.44
9
A
VAL
132
-45.34
-88.32
9
A
THR
133
47.15
8.07
9
A
ASP
134
-81.08
-83.97
9
A
PRO
136
-58.33
8.92
9
A
ALA
138
-104.19
-164.80
9
A
PRO
142
-68.37
14.67
9
A
ARG
150
50.88
15.39
9
A
ASP
151
83.07
20.23
9
A
TYR
161
-177.72
30.15
9
A
ARG
162
-80.02
36.40
9
A
THR
163
-68.09
1.95
9
A
ILE
168
-96.28
-67.86
9
A
ASP
176
-134.31
-51.11
10
A
ASN
25
-160.05
105.01
10
A
CYS
28
114.07
173.95
10
A
ASN
39
57.48
13.09
10
A
TYR
42
-72.06
28.58
10
A
SER
45
-122.28
-151.47
10
A
PHE
56
-108.40
43.59
10
A
ASN
57
29.66
77.53
10
A
CYS
77
-79.96
35.84
10
A
PRO
89
-72.67
-118.51
10
A
ILE
91
43.67
-98.71
10
A
HIS
92
-156.14
-54.09
10
A
ILE
96
-169.38
-32.92
10
A
ASN
100
-167.88
-80.57
10
A
ASN
101
-130.04
-150.58
10
A
VAL
104
39.09
42.24
10
A
LEU
107
-70.30
-141.97
10
A
THR
108
-159.81
17.32
10
A
SER
109
-132.92
-64.90
10
A
ASN
110
57.41
17.01
10
A
SER
112
-93.23
-104.16
10
A
GLN
113
-148.98
-90.21
10
A
TYR
114
103.57
-159.55
10
A
ASP
115
-115.15
-160.73
10
A
PRO
124
-52.39
170.34
10
A
GLU
126
171.35
-67.65
10
A
GLU
127
21.20
-141.85
10
A
ASP
128
177.28
-86.37
10
A
CYS
129
-143.29
36.82
10
A
SER
131
-38.79
97.53
10
A
THR
133
-64.48
17.15
10
A
ASP
134
-89.01
-76.26
10
A
PRO
136
-58.05
-2.09
10
A
ALA
138
-87.55
-154.41
10
A
ILE
143
-55.54
102.91
10
A
THR
144
-65.62
95.15
10
A
ARG
150
-58.70
-3.09
10
A
GLU
160
-163.87
34.09
10
A
ARG
162
-79.93
49.66
10
A
ASN
164
-119.38
71.39
10
A
ILE
168
-100.65
-63.72
10
A
TYR
169
-117.27
74.35
10
A
SER
171
56.13
86.72
10
A
THR
174
61.00
-88.84
10
A
ASP
175
56.84
-160.93
11
A
CYS
28
121.44
168.28
11
A
ALA
31
54.41
16.55
11
A
ASN
39
-49.80
104.73
11
A
ARG
41
-73.26
-165.65
11
A
TYR
42
160.42
-1.44
11
A
SER
45
-109.02
-162.00
11
A
THR
47
-32.75
-72.66
11
A
ALA
49
-45.15
-74.78
11
A
ALA
50
-28.75
-48.37
11
A
PHE
56
-100.78
58.08
11
A
ASN
57
26.74
75.45
11
A
PRO
61
-39.13
-70.61
11
A
THR
62
53.74
11.17
11
A
CYS
77
56.92
14.38
11
A
ILE
82
-106.08
-156.03
11
A
GLU
83
-48.10
-14.02
11
A
ARG
90
176.01
62.12
11
A
ILE
91
-48.84
151.71
11
A
HIS
92
66.05
146.92
11
A
ILE
96
-125.44
-71.24
11
A
CYS
97
-105.01
-83.89
11
A
ALA
99
59.39
-163.18
11
A
ASN
100
67.06
-92.37
11
A
THR
102
-92.17
-144.69
11
A
ASN
110
-63.19
-83.51
11
A
SER
112
52.89
-100.25
11
A
GLN
113
-132.15
-122.88
11
A
TYR
114
164.04
-159.66
11
A
ASP
115
-79.91
-162.52
11
A
GLU
126
-150.65
-77.31
11
A
GLU
127
-172.73
133.39
11
A
THR
130
-47.82
159.54
11
A
SER
131
-57.03
89.44
11
A
VAL
132
-63.61
10.98
11
A
THR
133
-51.30
5.18
11
A
ALA
138
-89.93
-157.71
11
A
PRO
142
-71.49
31.59
11
A
THR
144
-68.95
80.39
11
A
ARG
150
-49.67
-19.94
11
A
GLU
160
-162.13
101.92
11
A
ARG
162
-79.91
28.62
11
A
THR
174
-89.23
-83.42
11
A
ASP
175
59.26
15.57
11
A
ASP
176
-118.28
-162.66
11
A
ASP
177
58.89
18.03
12
A
CYS
28
151.79
-173.64
12
A
ALA
31
25.42
-95.74
12
A
ASN
39
-45.43
99.90
12
A
ARG
41
-71.81
-154.20
12
A
TYR
42
164.56
-3.36
12
A
SER
45
-117.21
-166.36
12
A
THR
47
-29.92
-73.36
12
A
GLU
48
-58.34
-70.90
12
A
ALA
49
-43.31
-70.16
12
A
CYS
53
-37.25
-37.86
12
A
PHE
56
-96.75
49.24
12
A
ASN
57
41.92
83.46
12
A
ILE
82
-107.93
-150.19
12
A
GLU
83
-58.33
1.03
12
A
PRO
89
-65.43
-132.77
12
A
ARG
90
74.90
84.40
12
A
HIS
92
-170.49
-49.61
12
A
PRO
93
-69.62
28.25
12
A
ASN
94
-140.32
-108.70
12
A
CYS
97
-78.91
-75.43
12
A
ALA
98
-62.27
-83.43
12
A
VAL
104
-69.26
91.69
12
A
SER
112
-63.95
-171.76
12
A
GLN
113
-84.43
-111.18
12
A
TYR
114
154.78
-160.06
12
A
ASP
115
-79.97
-160.31
12
A
CYS
118
-171.87
125.37
12
A
PRO
124
-70.76
-160.89
12
A
PRO
125
-88.65
48.07
12
A
GLU
126
-128.61
-95.11
12
A
ASP
128
-173.92
95.69
12
A
THR
130
-53.72
179.11
12
A
SER
131
-59.59
96.54
12
A
VAL
132
-83.79
31.34
12
A
THR
133
-63.73
18.48
12
A
ASP
134
-58.70
-109.90
12
A
PRO
136
-64.24
9.62
12
A
ALA
138
-60.73
-164.68
12
A
PRO
142
-70.68
26.03
12
A
THR
144
-65.14
84.56
12
A
GLU
160
-176.67
131.87
12
A
TYR
161
-174.30
24.46
12
A
THR
163
59.85
9.63
13
A
CYS
28
149.51
167.46
13
A
ALA
31
55.85
3.33
13
A
ASN
39
-48.90
99.52
13
A
SER
43
-43.66
-5.82
13
A
SER
45
-158.92
-134.03
13
A
ALA
50
-26.68
-56.93
13
A
PHE
56
-106.21
57.39
13
A
ASN
57
34.41
82.85
13
A
PRO
61
-35.90
-77.48
13
A
THR
62
179.24
-161.41
13
A
SER
71
-55.31
-7.59
13
A
ARG
78
-148.93
-107.27
13
A
TYR
79
-154.29
74.12
13
A
ILE
82
-100.46
-158.16
13
A
GLU
83
-49.67
-13.77
13
A
PRO
89
-64.14
-176.09
13
A
ARG
90
-167.24
3.74
13
A
ILE
91
61.27
-88.94
13
A
PRO
93
-73.23
24.36
13
A
SER
95
55.38
73.92
13
A
CYS
97
-85.70
-93.87
13
A
ALA
99
58.01
-175.75
13
A
THR
102
-78.45
-143.36
13
A
VAL
104
-143.79
48.43
13
A
SER
109
-172.30
114.79
13
A
THR
111
-175.31
-27.63
13
A
SER
112
-89.79
-121.71
13
A
TYR
114
174.56
-168.81
13
A
PRO
125
-66.72
71.42
13
A
SER
131
-31.05
92.14
13
A
THR
133
-63.03
14.97
13
A
ASP
134
-75.34
-87.99
13
A
PRO
136
-58.88
-3.46
13
A
PRO
142
-69.86
8.93
13
A
GLU
160
-170.00
136.25
13
A
TYR
161
-177.47
26.64
13
A
THR
163
58.47
11.59
13
A
PRO
165
-57.36
-9.00
13
A
THR
174
-69.24
-158.07
13
A
ASP
175
61.03
-159.55
14
A
CYS
28
131.88
175.37
14
A
ARG
29
-110.13
77.93
14
A
ALA
31
65.35
-11.26
14
A
LYS
38
75.26
-114.30
14
A
ASN
39
-57.63
-5.77
14
A
TYR
42
67.29
-13.81
14
A
SER
43
-141.72
23.59
14
A
SER
45
-132.43
-153.69
14
A
GLU
48
-53.21
-76.24
14
A
ASN
57
39.20
88.91
14
A
THR
59
-83.19
-147.04
14
A
LEU
60
-155.04
66.63
14
A
THR
62
58.23
-108.04
14
A
MET
63
-31.19
-38.90
14
A
TYR
79
-55.05
86.00
14
A
PHE
81
-45.97
152.20
14
A
ILE
82
-160.03
-164.52
14
A
HIS
85
92.97
-160.17
14
A
ARG
90
175.04
63.64
14
A
ILE
91
-59.21
-74.13
14
A
HIS
92
-155.06
54.04
14
A
PRO
93
-71.25
-91.74
14
A
ASN
94
-160.01
22.89
14
A
ALA
98
75.53
-46.58
14
A
ALA
99
60.90
-171.51
14
A
ASN
101
-179.11
147.35
14
A
VAL
104
-61.66
92.34
14
A
SER
112
-138.21
-90.28
14
A
GLN
113
-171.80
110.07
14
A
TYR
114
-147.43
-150.32
14
A
GLU
126
-176.24
-65.59
14
A
GLU
127
-179.91
120.83
14
A
THR
130
-46.43
155.58
14
A
THR
133
-60.54
12.49
14
A
ASP
134
-60.97
-108.90
14
A
PRO
136
-67.99
10.65
14
A
ALA
138
-62.32
-167.83
14
A
PHE
139
-113.05
-167.69
14
A
PRO
142
-74.33
32.69
14
A
TYR
161
-176.13
25.16
14
A
THR
163
57.15
11.97
14
A
ILE
168
-107.96
-67.61
14
A
TYR
169
-116.87
76.88
14
A
THR
174
-148.43
-29.98
14
A
ASP
177
53.69
-160.54
15
A
CYS
28
143.75
179.78
15
A
PHE
30
-79.96
-117.20
15
A
ALA
31
-49.24
2.16
15
A
ASN
39
24.22
41.08
15
A
ARG
41
29.02
86.65
15
A
TYR
42
79.90
-8.64
15
A
CYS
53
-39.60
-34.97
15
A
PHE
56
-116.32
64.15
15
A
ASN
57
16.48
69.93
15
A
THR
59
-108.30
-141.16
15
A
LEU
60
-163.65
65.73
15
A
THR
62
76.65
-124.23
15
A
SER
71
-58.15
1.85
15
A
CYS
77
55.79
14.46
15
A
ILE
82
-110.15
-150.94
15
A
PRO
89
-60.51
-174.07
15
A
ARG
90
-166.61
-51.47
15
A
ILE
91
56.26
-89.23
15
A
HIS
92
-169.69
-52.74
15
A
ALA
98
-62.01
-80.25
15
A
ALA
99
-148.87
-86.59
15
A
ASN
100
-140.60
-42.05
15
A
THR
111
-104.09
-67.63
15
A
SER
112
-161.09
-83.45
15
A
GLN
113
-152.06
-150.08
15
A
TYR
114
-167.76
-168.62
15
A
ASP
115
-97.42
-150.87
15
A
GLU
126
-159.04
-84.95
15
A
GLU
127
-163.46
119.67
15
A
THR
133
-57.47
4.98
15
A
ASP
134
-79.98
-81.28
15
A
PRO
136
-54.62
-2.61
15
A
PRO
142
-73.35
24.16
15
A
GLU
160
-170.49
132.63
15
A
TYR
161
-176.02
26.53
15
A
THR
163
57.53
15.90
15
A
ILE
168
-104.00
-65.61
15
A
PRO
170
-50.56
105.37
15
A
THR
174
-150.82
-26.43
16
A
CYS
28
126.63
168.80
16
A
ARG
29
-104.40
79.78
16
A
LYS
38
77.03
-122.15
16
A
ASN
39
-56.02
-9.70
16
A
TYR
42
63.13
-9.82
16
A
SER
43
-152.99
37.39
16
A
SER
45
-122.39
-165.23
16
A
GLU
48
-54.35
-74.80
16
A
CYS
53
-36.42
-35.47
16
A
ALA
55
-35.64
-35.87
16
A
PHE
56
-107.92
55.59
16
A
ASN
57
39.18
85.70
16
A
TYR
79
64.33
67.07
16
A
ILE
82
-111.31
-162.49
16
A
HIS
85
-174.66
141.74
16
A
PRO
89
-27.08
136.61
16
A
ILE
91
-62.36
-71.99
16
A
HIS
92
-171.75
42.21
16
A
PRO
93
-87.31
-100.35
16
A
ASN
94
-160.03
27.12
16
A
SER
95
69.56
155.17
16
A
ILE
96
72.25
104.45
16
A
ALA
99
-129.30
-66.45
16
A
ASN
101
72.18
121.31
16
A
THR
102
64.61
139.21
16
A
VAL
104
-51.67
100.39
16
A
SER
109
-153.29
44.92
16
A
ASN
110
59.46
17.88
16
A
THR
111
54.21
91.44
16
A
SER
112
-91.94
-88.51
16
A
TYR
114
-140.62
-143.90
16
A
GLU
126
-175.22
-56.93
16
A
GLU
127
-175.90
136.78
16
A
SER
131
-52.43
97.74
16
A
PRO
136
-52.56
10.15
16
A
PRO
142
-69.85
11.57
16
A
ILE
143
-54.09
101.65
16
A
THR
144
-65.36
77.11
16
A
ARG
150
52.84
12.97
16
A
ASP
151
85.84
5.37
16
A
GLU
160
-170.61
122.76
16
A
TYR
161
-176.70
25.57
16
A
ARG
162
-86.28
-71.02
16
A
ILE
168
-103.62
-66.52
16
A
TYR
169
-112.90
74.42
16
A
SER
171
60.32
102.60
16
A
ASP
176
-134.46
-30.93
17
A
CYS
28
128.97
176.07
17
A
ARG
29
-110.38
79.19
17
A
ALA
31
69.20
-13.39
17
A
ASN
39
-56.35
84.87
17
A
TYR
42
157.76
4.87
17
A
SER
43
-156.48
41.30
17
A
ALA
49
-50.83
-70.12
17
A
ASP
51
-60.22
-73.66
17
A
PHE
56
-92.65
43.90
17
A
CYS
77
-78.73
40.79
17
A
ILE
82
-111.84
-151.50
17
A
GLU
83
-55.88
-2.26
17
A
PRO
89
-62.76
-157.81
17
A
ARG
90
69.86
113.13
17
A
ILE
91
-58.13
-72.68
17
A
HIS
92
-166.19
54.16
17
A
PRO
93
-68.84
-79.88
17
A
ASN
94
-153.11
-15.20
17
A
SER
95
60.88
99.79
17
A
ALA
98
-65.14
-85.88
17
A
ALA
99
-158.95
-99.78
17
A
VAL
104
37.62
48.16
17
A
THR
108
-80.01
-98.77
17
A
THR
111
-153.30
-78.24
17
A
GLN
113
-75.29
-140.06
17
A
TYR
114
173.95
-159.31
17
A
ASP
115
-82.45
-159.48
17
A
GLU
126
-179.14
-67.16
17
A
GLU
127
172.52
121.06
17
A
THR
130
-43.36
154.21
17
A
SER
131
-49.02
94.12
17
A
THR
133
-63.95
19.67
17
A
ASP
134
-66.60
-110.40
17
A
PRO
136
-62.21
17.87
17
A
ALA
138
-60.79
-166.95
17
A
PRO
142
-70.40
25.97
17
A
ARG
150
-54.89
-8.14
17
A
GLU
160
-144.94
-65.67
17
A
TYR
161
48.24
23.32
17
A
ILE
168
-105.07
-63.88
17
A
TYR
169
-117.28
77.36
17
A
PRO
170
-50.49
-80.23
18
A
CYS
28
148.13
-169.25
18
A
ALA
31
53.85
8.34
18
A
ASN
39
29.07
35.21
18
A
ARG
41
31.82
84.87
18
A
TYR
42
79.95
-2.91
18
A
SER
45
-119.46
-166.33
18
A
ALA
49
-50.30
-77.81
18
A
PHE
56
-103.96
53.38
18
A
ASN
57
27.45
78.36
18
A
THR
59
-104.68
-153.56
18
A
LEU
60
-146.85
55.64
18
A
THR
62
79.12
-94.43
18
A
SER
71
-55.13
-4.52
18
A
CYS
77
47.05
22.98
18
A
HIS
85
88.96
-161.38
18
A
PRO
89
-66.78
-161.11
18
A
ARG
90
-173.23
-50.80
18
A
ILE
91
55.27
-88.76
18
A
HIS
92
-170.47
-53.67
18
A
ASN
94
-84.13
49.84
18
A
ALA
98
-128.86
-79.31
18
A
ALA
99
-153.27
-158.61
18
A
THR
108
-160.01
96.05
18
A
SER
109
-155.86
-89.50
18
A
THR
111
66.77
127.16
18
A
SER
112
-166.92
-87.44
18
A
TYR
114
-157.39
-156.76
18
A
GLU
126
-163.39
-59.72
18
A
GLU
127
-171.44
140.32
18
A
ASP
128
-162.98
115.71
18
A
THR
130
-54.79
-177.51
18
A
SER
131
-54.25
87.92
18
A
THR
133
-57.87
11.34
18
A
ASP
134
-54.01
-100.98
18
A
PRO
136
-62.83
8.59
18
A
ALA
138
-70.17
-159.95
18
A
PRO
142
-72.16
25.50
18
A
THR
144
-66.30
91.90
18
A
ARG
150
49.11
8.97
18
A
ASP
151
80.68
0.51
18
A
TYR
161
179.77
29.65
18
A
ARG
162
-85.05
39.40
19
A
CYS
28
131.99
170.70
19
A
ALA
31
56.22
11.99
19
A
ASN
39
-30.37
89.16
19
A
SER
43
169.05
-21.87
19
A
ILE
44
158.29
166.30
19
A
ARG
46
-73.04
-70.18
19
A
PHE
56
-107.77
65.38
19
A
ASN
57
19.92
69.09
19
A
CYS
77
-78.62
35.58
19
A
ILE
82
-106.57
-157.87
19
A
GLU
83
-52.18
-5.80
19
A
PRO
89
-58.52
-177.05
19
A
ARG
90
-161.82
-21.91
19
A
ASN
94
-155.91
59.07
19
A
ILE
96
57.49
15.68
19
A
CYS
97
-70.13
-78.52
19
A
ALA
99
64.68
155.81
19
A
ASN
100
58.65
19.89
19
A
THR
102
-158.18
6.29
19
A
VAL
104
-141.98
32.18
19
A
THR
108
-150.40
61.79
19
A
SER
109
-151.85
-145.48
19
A
CYS
118
-162.14
106.61
19
A
GLU
126
-171.64
-55.00
19
A
GLU
127
-171.04
133.39
19
A
SER
131
-30.19
104.21
19
A
VAL
132
-49.47
-95.39
19
A
THR
133
53.58
0.97
19
A
ASP
134
-75.49
-85.81
19
A
PRO
136
-61.78
10.72
19
A
PRO
142
-73.39
20.06
19
A
THR
144
-63.34
86.21
19
A
GLU
160
-173.07
131.65
19
A
TYR
161
-175.63
28.55
19
A
ARG
162
-80.89
37.89
19
A
THR
163
-64.79
4.34
19
A
ILE
168
-103.36
-70.26
20
A
CYS
28
125.48
178.76
20
A
ASN
39
19.45
44.49
20
A
ARG
41
27.22
88.30
20
A
TYR
42
80.15
-6.77
20
A
ALA
49
-47.66
-73.41
20
A
ASN
57
37.84
85.28
20
A
PRO
61
-53.69
10.92
20
A
THR
62
-42.28
-5.85
20
A
CYS
77
57.66
12.88
20
A
ILE
82
-82.13
-151.85
20
A
GLU
83
-48.97
-18.02
20
A
VAL
86
-52.72
100.31
20
A
ARG
90
-179.24
53.63
20
A
ILE
96
55.73
19.70
20
A
CYS
97
-95.94
-74.95
20
A
ALA
99
56.51
77.59
20
A
ASN
100
-138.43
-99.97
20
A
ASN
101
-174.31
-47.43
20
A
SER
109
-83.51
-152.33
20
A
THR
111
-63.61
-83.89
20
A
SER
112
53.42
-102.20
20
A
GLN
113
-172.81
-163.00
20
A
ASP
115
-98.21
-156.07
20
A
CYS
118
-169.65
118.49
20
A
GLU
126
166.79
-64.28
20
A
GLU
127
28.70
-146.42
20
A
ASP
128
-176.62
-149.37
20
A
VAL
132
-50.01
-88.73
20
A
THR
133
70.33
-22.72
20
A
PRO
136
-59.28
-1.90
20
A
ALA
138
-99.45
-149.81
20
A
PHE
139
-148.55
-115.63
20
A
THR
144
-59.76
90.36
20
A
GLU
160
178.19
152.10
20
A
TYR
161
-160.67
-31.44
20
A
PRO
165
-56.46
-9.41
20
A
SER
171
63.44
171.15
SOLUTION STRUCTURE OF THE HYALURONAN BINDING DOMAIN OF HUMAN CD44
1
N
N
A
SER
45
A
SER
26
HELX_P
A
PHE
56
A
PHE
37
1
1
12
A
THR
62
A
THR
43
HELX_P
A
ILE
72
A
ILE
53
1
2
11
A
ASN
164
A
ASN
145
HELX_P
A
ILE
168
A
ILE
149
5
3
5
disulf
2.031
A
CYS
28
A
SG
CYS
9
1_555
A
CYS
129
A
SG
CYS
110
1_555
disulf
2.029
A
CYS
53
A
SG
CYS
34
1_555
A
CYS
118
A
SG
CYS
99
1_555
disulf
2.030
A
CYS
77
A
SG
CYS
58
1_555
A
CYS
97
A
SG
CYS
78
1_555
CELL ADHESION
HYALURONAN-BINDING DOMAIN, CARBOHYDRATE-BINDING DOMAIN, LINK MODULE, CELL ADHESION, GLYCOPROTEIN
CD44_HUMAN
UNP
1
20
Q16208
AQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAA
NNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDV
20
178
1POZ
20
178
Q16208
A
1
1
159
3
3
2
2
3
parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
parallel
A
GLN
21
A
GLN
2
A
ASP
23
A
ASP
4
A
PHE
139
A
PHE
120
A
ASN
149
A
ASN
130
A
THR
153
A
THR
134
A
TYR
155
A
TYR
136
A
GLN
21
A
GLN
2
A
ASP
23
A
ASP
4
A
PHE
139
A
PHE
120
A
ASN
149
A
ASN
130
A
LYS
158
A
LYS
139
A
GLU
160
A
GLU
141
A
ARG
29
A
ARG
10
A
PHE
30
A
PHE
11
A
VAL
33
A
VAL
14
A
PHE
34
A
PHE
15
A
SER
58
A
SER
39
A
THR
59
A
THR
40
A
PHE
119
A
PHE
100
A
ASN
120
A
ASN
101
A
VAL
86
A
VAL
67
A
VAL
87
A
VAL
68
A
GLY
80
A
GLY
61
A
PHE
81
A
PHE
62
A
ASP
115
A
ASP
96
A
THR
116
A
THR
97